Supply Chain

New coalition, health plans, employers and legislators will want greater assurances that PBMs are controlling costs, Moody says.

Standard form EHR contracts can be a bit tricky to negotiate, according to Office of the National Coordinator for Health Information Technology.

The first drug to treat Duchenne muscular dystrophy could sell for $350,000 a year.

HHS says at least 2 million people become infected with antibiotic-resistant bacteria, with 23,000 dying as a result.

Rising concerns about spending on prescription drugs that treat rare diseases are not justified, according to a new analysis in the journal Health Affairs.

As of July 1, the FDA had 4,036 generic drug applications awaiting approval; median time it takes for the FDA to approve a generic is now 47 months.

Integrated healthcare delivery and financing company UPMC is taking steps to thwart wasteful spending and high costs in forming an independent company called Pensiamo, which aims to help hospitals improve supply chain performance with a source-to-pay offering, including cognitive analytics with IBM Watson Health Technologies.

While the legacy skin test is cheaper in terms of materials, it requires more staff time, and a greater commitment on the part of the patient.

The new rates, initiated on January 1, are being fully implemented on July 1, CMS said.

Boosting support for prescription drug monitoring programs, and establishing a consistent funding source, is strongly related to a reduction in opioid-related overdose deaths, says a new study from Health Affairs.